Morningstar Investor users sign in here.

Company Profile

  • Business description

    I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. Its first commercial drug will likely be eftansomatropin, a long-acting growth hormone that has a large market in China among pediatric patients with short stature, which we estimate will launch in 2024 or 2025. Other core assets include lemzoparlimab, a potential best-in-class CD47 inhibitor in phase 2 trials; uliledlimab, a potential best-in-class CD73 inhibitor in phase 2 trials; and felzartamab for the Chinese market, a CD38 inhibitor for multiple myeloma, which could have a phase 3 data readout in 2023.

  • Contact

    555 West Haiyang Road
    55th Floor, New Bund Center
    Pudong District
    Shanghai 200124
    CHN

    T: +86 2160578000

    https://www.i-mabbiopharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    318

I-MAB News & Analysis

stocks

10 of the cheapest US stocks of 2022

One silver lining of the bear market is half the US stocks followed by Morningstar analysts are now undervalued.
stocks

Chinese biotech: Buy the dip?

Morningstar looks at two diversified Chinese biotech names.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,892.10 31.10 0.40%
CAC 40 7,981.51 48.90 0.62%
DAX 40 17,770.02 3.79 0.02%
Dow JONES (US) 37,753.31 45.66 -0.12%
FTSE 100 7,847.99 27.63 0.35%
HKSE 16,251.84 2.87 0.02%
NASDAQ 15,683.37 181.88 -1.15%
Nikkei 225 37,647.68 314.12 -0.83%
NZX 50 Index 11,799.54 75.81 -0.64%
S&P 500 5,022.21 29.20 -0.58%
S&P/ASX 200 7,635.30 29.70 0.39%
SSE Composite Index 3,071.38 64.31 2.14%

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.03 0.00 -2.86%
Pantoro Ltd PNR 0.08 0.00 1.83%
Renascor Resources Ltd RNU 0.11 0.01 7.14%
Pilbara Minerals Ltd PLS 3.88 0.04 1.04%
Telstra Group Ltd TLS 3.68 0.01 -0.14%
Evolution Mining Ltd EVN 4.00 0.17 -3.97%
Bellevue Gold Ltd BGL 1.83 0.08 -3.94%
Mesoblast Ltd MSB 0.77 0.02 2.33%
Imugene Ltd IMU 0.08 0.00 1.20%
The Star Entertainment Group Ltd SGR 0.42 0.00 0.00%